Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) (NWG) vs Revvity Inc (RVTY) Price & Performance

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) vs Revvity Inc — how do they compare? NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.06 (market cap $66.98B), while Revvity Inc trades at $154.71 (market cap $16.98B). The key difference: NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) is far larger — about 3.9× Revvity Inc's market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays the higher dividend (5.5%). Which is the better fit depends on your goals — on Pluang, investors hold NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 0 Days and Revvity Inc for 12 Days on average.

NWGRVTY
Market Cap
$66.98B$16.98B
Volume
5,259,0601,456,900
Sector
FinancialsHealth
52-Week High
$19.42$157.36
52-Week Low
$13.89$82.26
Typical Hold Time
0 Days12 Days
Enterprise Value
$140.55B$19.30B
Dividend Yield
5.5%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)

No Aura AI signal available yet.

Revvity Inc

Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.

The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NWG
100% Buy0% Sell
Avg holding period · 0 Days
RVTY

No sentiment data available yet.

Top news

Latest headlines on both assets

About NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)

NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.

Read more on NWG →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →